LMR Partners’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-679
| Closed | -$26.4K | – | 885 |
|
|
2024
Q4 | $26.4K | Hold |
679
| – | – | ﹤0.01% | 655 |
|
|
2024
Q3 | $51.3K | Sell |
679
-84
| -11% | -$6.35K | ﹤0.01% | 558 |
|
|
2024
Q2 | $57.7K | Buy |
763
+671
| +729% | +$50.7K | ﹤0.01% | 526 |
|
|
2024
Q1 | $76.7K | Buy |
+92
| New | +$76.7K | ﹤0.01% | 529 |
|
|
2023
Q1 | – | Sell |
-8,333
| Closed | -$6.03M | – | 994 |
|
|
2022
Q4 | $6.03M | Hold |
8,333
| – | – | 0.11% | 222 |
|
|
2022
Q3 | $5.91M | Hold |
8,333
| – | – | 0.11% | 218 |
|
|
2022
Q2 | $5.89M | Hold |
8,333
| – | – | 0.1% | 244 |
|
|
2022
Q1 | $5.87M | Hold |
8,333
| – | – | 0.07% | 289 |
|
|
2021
Q4 | $5.83M | Hold |
8,333
| – | – | 0.06% | 229 |
|
|
2021
Q3 | $5.84M | Hold |
8,333
| – | – | 0.07% | 221 |
|
|
2021
Q2 | $5.78M | Buy |
+8,333
| New | +$5.78M | 0.09% | 186 |
|